Geron
GERN
#6671
Rank
โ‚ฌ0.73 B
Marketcap
1,14ย โ‚ฌ
Share price
-0.38%
Change (1 day)
6.29%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2026 (TTM): -โ‚ฌ30.34 Million

According to Geron's latest financial reports the company's current earnings are โ‚ฌ0.19 Billion. In 2025 the company made an earning of -โ‚ฌ44.27 Million, an increase over its 2024 earnings that were of -โ‚ฌ0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ30.34 Million-31.47%
2025 -โ‚ฌ44.27 Million-67.42%
2024 -โ‚ฌ0.14 Billion-11.23%
2023 -โ‚ฌ0.16 Billion30.22%
2022 -โ‚ฌ0.12 Billion20.15%
2021 -โ‚ฌ97.84 Million50.08%
2020 -โ‚ฌ65.19 Million4.46%
2019 -โ‚ฌ62.41 Million130.68%
2018 -โ‚ฌ27.06 Million8.84%
2017 -โ‚ฌ24.86 Million-3.08%
2016 -โ‚ฌ25.65 Million-22080.6%
2015 โ‚ฌ0.11 M-100.38%
2014 -โ‚ฌ30.99 Million-7.14%
2013 -โ‚ฌ33.37 Million
2011 -โ‚ฌ78.94 Million19.04%
2010 -โ‚ฌ66.32 Million8.45%
2009 -โ‚ฌ61.15 Million-2.51%
2008 -โ‚ฌ62.73 Million14.65%
2007 -โ‚ฌ54.71 Million32.68%
2006 -โ‚ฌ41.24 Million25.59%
2005 -โ‚ฌ32.84 Million4.36%
2004 -โ‚ฌ31.46 Million19.73%
2003 -โ‚ฌ26.28 Million-15.46%
2002 -โ‚ฌ31.09 Million1.94%
2001 -โ‚ฌ30.49 Million33.59%
2000 -โ‚ฌ22.83 Million27.53%
1999 -โ‚ฌ17.9 Million63.13%
1998 -โ‚ฌ10.97 Million15.6%
1997 -โ‚ฌ9.49 Million-10.66%
1996 -โ‚ฌ10.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚ฌ9.33 B-30,147.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚ฌ1.54 B-5,068.38%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚ฌ60.28 Million 93.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚ฌ0.13 B-539.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚ฌ12.99 Million-58.22%๐Ÿ‡บ๐Ÿ‡ธ USA